Cargando…
Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis
Nasopharyngeal carcinoma (NPC) is a unique malignancy derived from the epithelium of the nasopharynx. Despite great advances in the development of radiotherapy and chemotherapy, relapse and metastasis in NPC patients remain major causes of mortality. Evidence accumulated over recent years indicates...
Autores principales: | Wu, Chung-Chun, Chen, Mei-Shu, Cheng, Yu-Jhen, Ko, Ying-Chieh, Lin, Su-Fang, Chiu, Ing-Ming, Chen, Jen-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896023/ https://www.ncbi.nlm.nih.gov/pubmed/31731581 http://dx.doi.org/10.3390/cancers11111795 |
Ejemplares similares
-
EBV reactivation as a target of luteolin to repress NPC tumorigenesis
por: Wu, Chung-Chun, et al.
Publicado: (2016) -
Screening and identification of emodin as an EBV DNase inhibitor to prevent its biological functions
por: Wu, Chung-Chun, et al.
Publicado: (2023) -
The Role of NK Cells in EBV Infection and EBV-Associated NPC
por: Png, Yi Tian, et al.
Publicado: (2021) -
Epstein–Barr Virus (EBV) Rta-Mediated EBV and Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivations in 293 Cells
por: Chen, Yen-Ju, et al.
Publicado: (2011) -
Perspective: Contribution of Epstein–Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells
por: Wu, Chung-Chun, et al.
Publicado: (2018)